Search - tctmd.com

Displaying 401 - 420 of 688

Sort: Relevancy | Date

News Daily News

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Michael O'Riordan

June 08, 2016

News Daily News

Stimulant Drug Methylphenidate, Used for ADHD, Linked With Increased Risks of Arrhythmia, MI

Michael O'Riordan

June 01, 2016

News Daily News

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Todd Neale

May 27, 2016

News Daily News

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Shelley Wood

May 25, 2016

News Industry News

Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters

May 04, 2016

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Industry News

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

May 02, 2016

News Daily News

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Michael O'Riordan

April 29, 2016

News Industry News

Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial

April 28, 2016

News Industry News

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

April 20, 2016

News Industry News

Stroke Prevention: BIOTRONIK Announces FDA Approval of BioMonitor 2 Insertable Cardiac Monitor

April 12, 2016

News Industry News

FDA Approves World's Smallest Pacemaker for U.S. Patients

April 07, 2016

News Conference News ACC 2016

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

Caitlin E. Cox

April 03, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Industry News

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

March 06, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Industry News

Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans

February 21, 2016

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

February 04, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

Advertisement

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Stimulant Drug Methylphenidate, Used for ADHD, Linked With Increased Risks of Arrhythmia, MI

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

Stroke Prevention: BIOTRONIK Announces FDA Approval of BioMonitor 2 Insertable Cardiac Monitor

FDA Approves World's Smallest Pacemaker for U.S. Patients

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content